Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK-0657

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Learning objective After participating in this activity, learners should be better able to evaluate the evidence supporting the… Expand
2017
2017
Objectives Blockade of N-methyl-D-aspartate receptors containing the NR2B subunit has been shown to be therapeutic in animal… Expand
Review
2017
Review
2017
Current pharmacotherapies for major depressive disorder (MDD) have a distinct lag of onset that can prolong distress and… Expand
  • table 1
  • table 2
Review
2017
Review
2017
Current therapeutic options for major depressive disorder (MDD) and bipolar disorder (BD) are associated with a lag of onset that… Expand
  • figure 1
  • table 1
Review
2016
Review
2016
Major depression is a common, recurrent mental illness that affects millions of people worldwide. Recently, a unique fast… Expand
2015
2015
N-methyl-D-aspartate (NMDA) receptor antagonists, including open channel blockers and GluN2B receptor subtype selective… Expand
Review
2014
Review
2014
Introduction: Mood disorders, including depression, are becoming increasingly prevalent in the developed world. Furthermore… Expand
Review
2013
Review
2013
Severe psychiatric disorders such as schizophrenia are related to cognitive and negative symptoms, which often are resistant to… Expand
  • figure 1
  • figure 2
Highly Cited
2012
Highly Cited
2012
Abstract Converging lines of evidence suggest that the glutamatergic system may play an increasingly important role in the… Expand
2009
2009
The glutamatergic system is thought to contribute to the motor disturbances observed in Parkinson's disease. Blockade of… Expand